CBE CBE Metabolic and Comorbidity Management

Question 1

Which comorbidity shows the most rapid improvement or remission following Roux-en-Y gastric bypass (RYGB)?

Accepted Answer

Type 2 diabetes mellitus

Answer

Type 2 diabetes often remits within days of RYGB, even before significant weight loss, due to gut hormone changes including increased GLP-1 secretion.

Question 2

A bariatric patient with pre-existing hypertension is 3 months post-surgery and has lost 50 lbs. What medication adjustment is most likely needed?

Accepted Answer

Antihypertensive doses may need to be reduced or discontinued

Answer

Significant weight loss after bariatric surgery frequently leads to blood pressure normalization, requiring reduction or elimination of antihypertensive medications to prevent hypotension.

Question 3

Which metabolic marker is most directly used to monitor type 2 diabetes remission after bariatric surgery?

Accepted Answer

Hemoglobin A1c (HbA1c)

Answer

HbA1c reflects average blood glucose over 2–3 months and is the standard metric for determining if type 2 diabetes is in remission following bariatric surgery.

Question 4

Obstructive sleep apnea (OSA) is a common comorbidity in bariatric patients. After significant weight loss, what follow-up is required?

Accepted Answer

Repeat sleep study to reassess CPAP/BiPAP needs

Answer

Weight loss substantially reduces upper airway fat deposits, so CPAP pressure requirements often change or OSA resolves entirely, requiring a repeat sleep study for adjustment.

Question 5

Which lipid abnormality most commonly improves after bariatric surgery?

Accepted Answer

Hypertriglyceridemia

Answer

Elevated triglycerides are strongly associated with obesity and insulin resistance, both of which improve dramatically after bariatric surgery, leading to triglyceride normalization.

CBE - Certified Bariatric Educator Practice Test

CBE - Certified Bariatric Educator Practice Test

CBE CBE Metabolic and Comorbidity Management